A 59-year-old woman with a 6-month history of exertional dyspnea and worsening fatigue underwent cardiac magnetic resonance imaging (CMR) to further characterize a left ventricular mass incidentally noted on transthoracic echocardiography. The mass attached to the mid-anterior wall, measured 2.6 cm in its major axis, and displayed the following tissue characteristics: hyperintensity to myocardium with T1 weighted imaging (Figure 1 A, B), lack of perfusion with first-pass imaging of gadolinium-based contrast agent (Figure 1 C), and signal loss with T2 weighted fat saturation sequences (Figure 1 D). Combined computed tomography (CT) and positron emission tomography (PET) imaging revealed a hypodense mass that did not enhance with contrast administration, Hounsfield units of 82 consistent with adipose density, and low uptake of fluorodeoxyglucose (Figures 2, 3). In summation, the findings were virtually diagnostic of an intracardiac lipoma.
Cardiac lipomas are primary tumors of the heart that consist of an encapsulated collection of adipocytes. Although classified as benign lesions, they may lead to symptoms depending on their size, location, and compressive effects on cardiac chambers or interference with the conduction system. Whether cardiac1,2 or extracardiac,3 lipomas display characteristic CMR findings, with the elegant demonstration of hypointensity on fat suppression imaging being its sina qua non feature. Supportive CT findings include an encapsulated mass with fat density Hounsfield units usually between 90 and 110 and homogeneous hypoenhancement with the administration of iodine-based contrast.1,2 Although the role of PET is less well established for cardiac lipomas, extracardiac lipomas demonstrate reduced metabolic activity as evidenced by low avidity for fluorodeoxyglucose with correspondingly low standardized uptake values.4,5
Our case demonstrates classic noninvasive cardiac imaging findings of this tumor type. A conservative watch and wait strategy was recommended, and repeat CMR 3 months later did not demonstrate interval growth of the lipoma.